Next Century Growth Investors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Next Century Growth Investors’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-961,379	Closed	-$14.4M	–	130
2023 Q3	$14.4M	Buy	961,379 +221,464	+30%	+$4.61M	1.57%	20
2023 Q2	$24M	Buy	739,915 +80,610	+12%	+$2.94M	2.32%	14
2023 Q1	$25.8M	Sell	659,305 -19,661	-3%	-$962K	2.84%	8
2022 Q4	$35.9M	Sell	678,966 -54,474	-7%	-$2.65M	4.31%	3
2022 Q3	$33M	Buy	733,440 +159	+0%	+$6.84K	4.03%	3
2022 Q2	$26.7M	Buy	733,281 +90,981	+14%	+$3.31M	3.49%	4
2022 Q1	$26.5M	Buy	642,300 +107,649	+20%	+$3.79M	2.65%	6
2021 Q4	$22.8M	Buy	534,651 +50,433	+10%	+$2.52M	2.05%	9
2021 Q3	$26.6M	Sell	484,218 -24,103	-5%	-$1.26M	2.31%	8
2021 Q2	$24.3M	Sell	508,321 -66,642	-12%	-$3.4M	1.9%	14
2021 Q1	$29.1M	Buy	574,963 +261,429	+83%	+$14.5M	2.22%	10
2020 Q4	$19.7M	Sell	313,534 -30,806	-9%	-$1.91M	1.66%	16
2020 Q3	$23.1M	Sell	344,340 -147,222	-30%	-$8.04M	2.41%	7
2020 Q2	$20.6M	Buy	491,562 +35,451	+8%	+$1.36M	2.34%	7
2020 Q1	$14.4M	Buy	456,111 +31,237	+7%	+$1.25M	2.33%	8
2019 Q4	$17.2M	Buy	424,874 +359,574	+551%	+$12.6M	2.23%	11
2019 Q3	$2.12M	Buy	65,300 +51,833	+385%	+$2.06M	0.34%	84
2019 Q2	$652K	Buy	+13,467	New	+$573K	0.08%	125

Other funds holding SILK

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Next Century Growth Investors's SILK Position: Q4 2023 in Review

Next Century Growth Investors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2023, closing a stake of 961,379 shares — an estimated $14.4M sold.

Next Century Growth Investors first reported a position in SILK in Q2 2019 and held it in 18 quarters. The position peaked at $35.9M in Q4 2022. 133 funds tracked by Wall St. Rank hold SILK as of Q4 2023.

Next Century Growth Investors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Next Century Growth Investors sold 961,379 Silk Road Medical, Inc. Common Stock shares in Q4 2023, an estimated $14.4M.
Next Century Growth Investors first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 18 quarters.
Next Century Growth Investors's Silk Road Medical, Inc. Common Stock position peaked at $35.9M in Q4 2022.
133 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2023.

Based on Next Century Growth Investors's 13F filing for Q4 2023, filed 14 Feb 2024.